Effect of nebulized eucalyptus on arterial blood gas and physiologic indexes

Effect of nebulized eucalyptus on arterial blood gas and physiologic indexes of ventilated patients:A Double-Blind Randomized Clinical Trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180107038251N2

Enrollment

Registered

2019-07-20

Start date

2014-08-11

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arterial blood gases analysis in mechanical ventilated patients. Dependence on respirator

Interventions

Intervention 1: Intervention group: Four ml of 5% eucalyptus made by medicinal herbs department in arak university will be diluted in 10 ml normal saline and will be nebulized in about 20 minutes thro

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Oral intubation 18-65 years old Lack of pulmonary infection No sepsis No pulmonary thromboembolism No atelectasis No gasterointestinal inflammatory disease No severe hepatic disease No allergy to herbal compounds

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
PH. Timepoint: Before intervention, three days after the start of intervention (third day),. Method of measurement: The GEM Premier 3000 device is used.;Hco3. Timepoint: Before intervention, three days after the start of intervention (third day). Method of measurement: The GEM Premier 3000 device is used.;Base excess. Timepoint: Before intervention, three days after the start of intervention (third day). Method of measurement: The GEM Premier 3000 device is used.;Pao2. Timepoint: Before intervention, three days after the start of intervention (third day). Method of measurement: The GEM Premier 3000 device is used.;Sao2. Timepoint: Before intervention, three days after the start of intervention (third day). Method of measurement: The GEM Premier 3000 device is used.;Paco2. Timepoint: Before intervention, three days after the start of intervention (third day). Method of measurement: The GEM Premier 3000 device is used.;Systolic blood pressure. Timepoint: Before intervention, three days after the start of intervention (third day). Method of measurement: automatic blood pressure from Cardio set x-110 IEI device was used to measure blood pressure.;Diastolic blood pressure. Timepoint: Before intervention, three days after the start of intervention (third day). Method of measurement: automatic blood pressure from Cardio set x-110 IEI device was used to measure blood pressure.;Temperature. Timepoint: Before intervention, three days after the start of intervention (third day). Method of measurement: thermometer.;Respiratory rate. Timepoint: Before intervention, three days after the start of intervention (third day). Method of measurement: respiratory rate per minute.;Pulse rate. Timepoint: Before intervention, three days after the start of intervention (third day). Method of measurement: pals oximeter.;Level of consciousness. Timepoint: Before intervention, three days after the start of intervention (third day). Method of measurement: Glasgow Coma Scale.;Peak inspiratory pre	—

Measure

Time frame

PH. Timepoint: Before intervention, three days after the start of intervention (third day),. Method of measurement: The GEM Premier 3000 device is used.;Hco3. Timepoint: Before intervention, three days after the start of intervention (third day). Method of measurement: The GEM Premier 3000 device is used.;Base excess. Timepoint: Before intervention, three days after the start of intervention (third day). Method of measurement: The GEM Premier 3000 device is used.;Pao2. Timepoint: Before intervention, three days after the start of intervention (third day). Method of measurement: The GEM Premier 3000 device is used.;Sao2. Timepoint: Before intervention, three days after the start of intervention (third day). Method of measurement: The GEM Premier 3000 device is used.;Paco2. Timepoint: Before intervention, three days after the start of intervention (third day). Method of measurement: The GEM Premier 3000 device is used.;Systolic blood pressure. Timepoint: Before intervention, three days after the start of intervention (third day). Method of measurement: automatic blood pressure from Cardio set x-110 IEI device was used to measure blood pressure.;Diastolic blood pressure. Timepoint: Before intervention, three days after the start of intervention (third day). Method of measurement: automatic blood pressure from Cardio set x-110 IEI device was used to measure blood pressure.;Temperature. Timepoint: Before intervention, three days after the start of intervention (third day). Method of measurement: thermometer.;Respiratory rate. Timepoint: Before intervention, three days after the start of intervention (third day). Method of measurement: respiratory rate per minute.;Pulse rate. Timepoint: Before intervention, three days after the start of intervention (third day). Method of measurement: pals oximeter.;Level of consciousness. Timepoint: Before intervention, three days after the start of intervention (third day). Method of measurement: Glasgow Coma Scale.;Peak inspiratory pre

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNazanin Amini

Arak University of Medical Sciences

nazaninamini69@yahoo.com+98 34173507

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026